UA99211C2 - Nanocapsules with functions of nanorobot - Google Patents

Nanocapsules with functions of nanorobot

Info

Publication number
UA99211C2
UA99211C2 UAA201104513A UAA201104513A UA99211C2 UA 99211 C2 UA99211 C2 UA 99211C2 UA A201104513 A UAA201104513 A UA A201104513A UA A201104513 A UAA201104513 A UA A201104513A UA 99211 C2 UA99211 C2 UA 99211C2
Authority
UA
Ukraine
Prior art keywords
nanorobot
nanocapsules
functions
hydroxoapatite
biology
Prior art date
Application number
UAA201104513A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Петр Петрович Горбик
Алла Леонидовна Петрановская
Маргарита Петровна Турелик
Светлана Петровна Туранская
Александра Анатолиевна Васильева
Василий Федорович Чехун
Наталья Юрьевна Лукьянова
Анатолий Петрович Шпак
Алексей Михайлович Кордубан
Original Assignee
Институт Химии Поверхности Им. А.А. Чуйко Нан Украины
Институт Экспериментальной Патологии, Онкологии И Радиобиологии Им. Р.Е. Кавецкого Нан Украины
Институт Металофизики Им. Г.В. Курдюмова Национальной Академии Наук Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институт Химии Поверхности Им. А.А. Чуйко Нан Украины, Институт Экспериментальной Патологии, Онкологии И Радиобиологии Им. Р.Е. Кавецкого Нан Украины, Институт Металофизики Им. Г.В. Курдюмова Национальной Академии Наук Украины filed Critical Институт Химии Поверхности Им. А.А. Чуйко Нан Украины
Priority to UAA201104513A priority Critical patent/UA99211C2/en
Publication of UA99211C2 publication Critical patent/UA99211C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to nanocapsules with functions of nanorobot and can be used in medicine and biology for the early detection and therapy of cancer at cell level. The nanocapsule comprises magnetite, hydroxoapatite as modifying agent, cytotoxic preparation and conjugated monoclonal antibody.
UAA201104513A 2011-04-13 2011-04-13 Nanocapsules with functions of nanorobot UA99211C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201104513A UA99211C2 (en) 2011-04-13 2011-04-13 Nanocapsules with functions of nanorobot

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201104513A UA99211C2 (en) 2011-04-13 2011-04-13 Nanocapsules with functions of nanorobot

Publications (1)

Publication Number Publication Date
UA99211C2 true UA99211C2 (en) 2012-07-25

Family

ID=50848635

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201104513A UA99211C2 (en) 2011-04-13 2011-04-13 Nanocapsules with functions of nanorobot

Country Status (1)

Country Link
UA (1) UA99211C2 (en)

Similar Documents

Publication Publication Date Title
MX352738B (en) Cytotoxic peptides and antibody drug conjugates thereof.
TN2015000396A1 (en) Antibody drug conjugates
TN2015000050A1 (en) Methods of treating a tauopathy
CA3019531A1 (en) Combinations of anti-4-1bb antibodies and adcc-inducing antibodies for the treatment of cancer
NZ731633A (en) Antibodies against cd73 and uses thereof
NZ631197A (en) Anti sez6 antibodies and methods of use
WO2017031458A3 (en) Anti-dll3 antibody drug conjugates and methods of use
MX369106B (en) Anti-human trop-2 antibody having antitumor activity in vivo.
IN2014DN09098A (en)
NZ628314A (en) Cd47 antibodies and methods of use thereof
WO2013114367A8 (en) C10rf32 antibodies, and uses thereof for treatment of cancer
AU2012335543A8 (en) HER3 antibodies and uses thereof
MX2015005963A (en) Heterocyclic glutaminase inhibitors.
WO2013006490A3 (en) Antibodies that specifically bind to tim3
UA112288C2 (en) Antibody forvulation and therapeutic regimens
WO2014163714A3 (en) Antibody drug conjugates
NZ704718A (en) Epcam aptamer for detection of cancer stem cells
MX347734B (en) S100a4 antibodies and therapeutic uses thereof.
EP2519542A4 (en) Anti-cdh3 antibodies and uses thereof
BR112014027905A2 (en) antibody, cell, nucleic acid, methods of identifying a first antibody, inhibiting cell growth, therapeutic treatment, determining the presence of a protein, diagnosing a tumor, and delivering a cytotoxic agent.
HK1210713A1 (en) Anti-lamp1 antibodies and antibody drug conjugates, and uses thereof -lamp1
EA201992513A1 (en) BREAST CANCER TREATMENT METHOD
IL227687A0 (en) Anti-alpha-v integrin antibody for use in the treatment of prostate cancer
MX2013002718A (en) Anti-vegfr-3 antibody compositions.
UY34154A (en) DOSAGE AND ADMINISTRATION OF ANTI-ERBB3 ANTIBODIES IN COMBINATION WITH PACLITAXEL.